Skip to main content
PeopleBio, Inc. logo

PeopleBio, Inc. — Investor Relations & Filings

Ticker · 304840 ISIN · KR7304840002 KO Manufacturing
Open in API
Filings indexed 250 across all filing types
Latest filing 2022-05-30 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 304840

About PeopleBio, Inc.

http://www.peoplebio.net/en/PEOPLEBIO.p…

PeopleBio, Inc. is a biotechnology company specializing in the development and manufacturing of diagnostic products for protein misfolding diseases. The company's primary focus is on degenerative brain disorders, particularly Alzheimer's disease. It develops blood-based diagnostic kits and immunoassays designed for early detection. By providing tools for early diagnosis, PeopleBio aims to facilitate timely intervention and treatment, thereby improving patient outcomes for these conditions.

Recent filings

Filing Released Lang Actions
분기보고서 (2022.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '피플바이오' (PeopleBio) covering the period from January 1, 2022, to March 31, 2022. It contains detailed financial information, business operations, capital structure, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-05-30 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Peptron/PeopleBio) regarding a 'Single Sales/Supply Contract' amendment. It details changes to contract dates and terms due to regulatory shifts in Singapore. Since this is a specific corporate disclosure regarding a commercial contract and does not fit into categories like financial reports, dividends, or board changes, it falls under the general regulatory filing category.
2022-04-29 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (PeopleBio) announcing a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). This is a standard material event disclosure required by the Korea Exchange (KRX) for significant contracts. Since it does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2022-04-26 Korean
[기재정정]사업보고서 (2021.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the company 'PeopleBio' (주식회사 피플바이오) for the fiscal year 2021. It contains detailed financial information, company history, capital structure, and management details. In the South Korean regulatory context, the '사업보고서' is the equivalent of the US 10-K annual report. The document is clearly the full report itself, not an announcement or a summary. FY 2021
2022-03-29 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (정기주주총회결과). It details the approval of financial statements, director appointments, and voting outcomes for specific agenda items. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2022-03-28 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by the company PeopleBio. It contains key financial data, audit opinions, and financial statements for the fiscal year. While it provides financial highlights, it is a regulatory filing announcing the completion and submission of the audit report to the exchange (KRX), which is standard practice for Korean listed companies. Given the structure and the specific regulatory nature of the disclosure, it falls under the 'Regulatory Filings' category as it serves as an official notice of the audit report's availability. FY 2021
2022-03-18 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.